THE DRUG RESISTANCE MUTATIONS OF THE HEPATITIS B VIRUS AMONG HIV-INFECTED INDIVIDUALS

par Yu. V. Ostankova
Publié 2018

THE SIGNIFICANCE OF THE HIV RESISTANCE ANALYSIS IN ANTIRETROVIRAL THERAPY

par D. E. Valutite, Yu. V. Ostankova
Publié 2018

DEVELOPMENT AND APPROBATION METHOD OF IDENTIFICATION MUTATIONS THE RESISTANCE OF THE HEPATITIS C VIRUS TO DIRECT-ACTING ANTIVIRAL AGENTS (DAAs)

par D. E. Valutite, Yu. V. Ostankova
Publié 2018

THE PREVALENCE AND MOLECULAR EPIDEMIOLOGY OF STENOTROPHOMONAS MALTOPHILA IN THE INTENSIVE CARE UNITS

par E. V. Zueva, Yu. V. Ostankova, E. B. Zueva
Publié 2018

THE PREVALENCE OF HIV-1 DRUG RESISTANCE MUTATIONS IN PATIENTS WITH LOW ADHERENCE TO ANTIRETROVIRAL THERAPY IN THE LENINGRAD REGION

par A. N. Shchemelev, Yu. V. Ostankova, D. E. Valutite
Publié 2018

HEPATITIS B VIRUS IDENTIFICATION IN THE ENSURING INFECTIOUS SAFETY OF BLOOD TRANSFUSIONS

par Yu. V. Ostankova, E. B. Zueva, D. E. Valutite
Publié 2018

HEPATITIS A PREVALENCE AMONG CHILDREN IN BOKE AND KINDIA PROVINCES (REPUBLIC OF GUINEA)

par E. V. Esaulenko, A. A. Sukhoruk, A. V. Semenov, Yu. V. Ostankova, S. Boumbali
Publié 2018

GENETIC VARIANTS OF HEPATITIS B VIRUS IN PRIMARY DONORS IN ASTANA, KAZAKHSTAN

par Yu. V. Ostankova, A. V. Semenov, Z. K. Burkitbayev, T. N. Savchuk, A. A. Totolian
Publié 2017

RESULTS OF GENOTYPING HEPATITIS VIRUS B IN HBsAg-NEGATIVE BLOOD DONORS IN ASTANA, KAZAKHSTAN

par Yu. V. Ostankova, A. V. Semenov, Z. K. Burkitbayev, T. N. Savchuk, A. A. Totolian
Publié 2018

MOLECULAR EPIDEMIOLOGY FEATURES OF HBV/HDV CO-INFECTION IN KYRGYZSTAN

par A. V. Semenov, Yu. V. Ostankova, K. A. Nogoybaeva, K. T. Kasymbekova, I. N. Lavrentieva, S. T. Tobokalova, Areg A. Totolian
Publié 2016

DETECTION OF PARVOVIRUS INFECTION MARKERS IN RISK GROUPS

par I. V. Khamitova, A. Yu. Antipova, M. Yu. Averyanova, A. E. Levkоvskyi, Yu. V. Ostankova, A. V. Semenov, A. B. Chukhlovin, I. N. Lavrentieva
Publié 2018